|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29,750 KRW | -1.16% |
|
-2.14% | +48.01% |
BIOCND Inc. (XKON:A217950) announced a private placement of 554,632 common shares of par value KRW 500 at KRW 18,030 per share for gross proceeds of KRW 10,000,014,960 to Pharma Research Products Co., Ltd (KOSDAQ:A214450) on January 26, 2018. The common shares have a lock up period of 12 months. The transaction has been approved by the board of directors of the company.
The transaction is expected to close on April 3, 2018
| 1st Jan change | Capi. | |
|---|---|---|
| +48.01% | 88.97M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -2.74% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
PHARMARESEARCH BIO CO., LTD. 
